Chromatin Modulation Associated with DNA Breakage and Repair in Human Cells
与人类细胞 DNA 断裂和修复相关的染色质调节
基本信息
- 批准号:8202555
- 负责人:
- 金额:$ 10.39万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2011
- 资助国家:美国
- 起止时间:2011-07-01 至 2011-10-31
- 项目状态:已结题
- 来源:
- 关键词:AcetylationAddressAffectAtaxia-Telangiectasia-Mutated protein kinaseBRCA1 ProteinBRCA1 geneBindingBiochemicalCancer-Predisposing GeneCell LineCell SurvivalCellsCellular biologyChromatinComplexDNADNA DamageDNA Double Strand BreakDNA LigationDNA RepairDevelopmentDiseaseDouble Strand Break RepairEndonuclease IEnzymesEukaryotaEventFunctional disorderFungal GenomeGenerationsGenetic TranscriptionHomingHumanHuman GenomeKineticsLaboratoriesLeadLigationMalignant NeoplasmsMammalian CellMedicineMethodsModelingModificationMolecularMolecular ProbesMovementMutagenesisNatureNucleosomesOutcomePhosphorylationPredispositionProcessProtein BindingProteinsRadiation therapyRegulationReportingRoleSignal PathwaySignal Transduction PathwaySiteStressSystemTechniquesUbiquitinationbasecancer therapychemotherapychromatin proteinendonucleasehuman diseaseimprovedinsightinterestmalignant breast neoplasmnovelnovel strategiesnucleasepreventrepairedresearch studyresponserestorationtumor
项目摘要
DESCRIPTION (provided by applicant): Cellular responses to DNA damage and other stresses are important determinants of cell viability and mutagenesis and impact the development of a wide range of human diseases. DNA damage responses, in particular, are major determinants of both cancer development and outcomes of cancer therapies. Induction of signal transduction pathways is a critical aspect of cellular responses to these stresses and significant advances have been made in recent years elucidating the biochemical steps in such signaling pathways. Clarification of such steps enables modulation of these responses, which can enhance research studies and can lead to the generation of new medicines to prevent and treat these diseases. This application describes an enhancement of a novel technique developed in the Kastan laboratory in which DNA double strand breaks (DSBs) are introduced at defined sites in the human genome. Introduction of site-directed DNA damage permits studies of molecular events occurring at and around the DSB and direct assessment of repair (re- ligation) of DNA breaks. The enhancements of this technique permit greater temporal control of introduction of the DSBs and allow assessment of the kinetics and completeness of DSB repair. This enhanced approach will be used in the experiments proposed in this application to elucidate the dynamic changes in protein movements/modifications occurring at and around the DSB and explore factors which may determine efficiency of repair of the DNA breaks. One major focus is exploration of the molecular controls of nucleosome disruption at the DSB site and elucidating the functional importance of this nucleosomal disruption. It is well established that numerous modifications occur in chromatin-associated proteins surrounding DSBs during the damage/repair process; however, the functional role(s) of many of these modifications, especially related to DNA repair, remain to be clarified. Experiments are proposed that will use this novel system to explore the potential impact of these chromatin changes surrounding the DSBs on the ability of the cell to repair (re-ligate) DNA breaks. Further, the mechanisms and impact of the breast cancer susceptibility gene product, Brca1, on this process will be investigated. The proposed studies will provide novel insights into molecular mechanisms associated with the DNA DSB repair process in human cells.
PUBLIC HEALTH RELEVANCE: DNA damage and repair are critical determinants of cancer development and responses of tumors to chemotherapy and radiation therapy. Based on a novel system developed to probe molecular events associated with DNA breakage in human cells, studies are proposed to explore factors that affect the ability of human cells to repair DNA double strand breaks. Insights gained into these mechanisms associated with cellular responses to DNA damage will improve our understanding of cancer predisposition and development and have the potential to lead to development of new approaches to enhancing tumor responses to therapy.
描述(由申请人提供):细胞对DNA损伤和其他应激的反应是细胞活力和诱变的重要决定因素,并影响多种人类疾病的发展。特别是DNA损伤反应是癌症发展和癌症治疗结果的主要决定因素。信号转导途径的诱导是细胞对这些应激反应的一个重要方面,近年来在阐明这些信号转导途径中的生物化学步骤方面取得了重大进展。澄清这些步骤有助于调节这些反应,这可以加强研究,并可能导致产生新的药物来预防和治疗这些疾病。本申请描述了Kastan实验室开发的一种新技术的增强,其中在人类基因组中的限定位点引入DNA双链断裂(DSB)。引入定点DNA损伤允许研究在DSB处和周围发生的分子事件,并直接评估DNA断裂的修复(重新连接)。该技术的改进允许更好地控制DSB的引入,并允许评估DSB修复的动力学和完整性。这种增强的方法将用于本申请中提出的实验中,以阐明在DSB处和周围发生的蛋白质移动/修饰的动态变化,并探索可能决定DNA断裂修复效率的因素。一个主要的焦点是探索在DSB网站的核小体破坏的分子控制,并阐明这种核小体破坏的功能重要性。众所周知,在损伤/修复过程中,DSB周围的染色质相关蛋白发生了许多修饰;然而,这些修饰中的许多修饰,特别是与DNA修复相关的修饰的功能作用仍有待澄清。实验提出,将使用这种新的系统,以探索这些染色质的变化DSB周围的细胞修复(重新连接)DNA断裂的能力的潜在影响。此外,乳腺癌易感基因产物Brca 1对这一过程的机制和影响将被研究。拟议的研究将为人类细胞中DNA DSB修复过程相关的分子机制提供新的见解。
公共卫生相关性:DNA损伤和修复是癌症发展和肿瘤对化疗和放疗的反应的关键决定因素。基于一种新的系统开发,以探测与人类细胞中DNA断裂相关的分子事件,研究提出探索影响人类细胞修复DNA双链断裂能力的因素。对这些与细胞对DNA损伤的反应相关的机制的深入了解将提高我们对癌症易感性和发展的理解,并有可能导致开发新的方法来增强肿瘤对治疗的反应。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Michael B Kastan其他文献
Michael B Kastan的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Michael B Kastan', 18)}}的其他基金
Defining the genomic and microenvironmental features of diffuse large B cell lymphoma in HIV + patients (Biospecimens/Biocohort)
定义 HIV 患者弥漫性大 B 细胞淋巴瘤的基因组和微环境特征(生物样本/生物队列)
- 批准号:
10619709 - 财政年份:2022
- 资助金额:
$ 10.39万 - 项目类别:
Chromatin Modulation Associated with DNA Breakage and Repair in Human Cells
与人类细胞 DNA 断裂和修复相关的染色质调节
- 批准号:
8796446 - 财政年份:2011
- 资助金额:
$ 10.39万 - 项目类别:
Chromatin Modulation Associated with DNA Breakage and Repair in Human Cells
与人类细胞 DNA 断裂和修复相关的染色质调节
- 批准号:
8387220 - 财政年份:2011
- 资助金额:
$ 10.39万 - 项目类别:
ATM, REACTIVE OXYGEN, AND CELLULAR RESPONSES TO HYPOXIA
ATM、活性氧和细胞对缺氧的反应
- 批准号:
8368238 - 财政年份:2011
- 资助金额:
$ 10.39万 - 项目类别:
Chromatin Modulation Associated with DNA Breakage and Repair in Human Cells
与人类细胞 DNA 断裂和修复相关的染色质调节
- 批准号:
8657907 - 财政年份:2011
- 资助金额:
$ 10.39万 - 项目类别:
ATM, REACTIVE OXYGEN, AND CELLULAR RESPONSES TO HYPOXIA
ATM、活性氧和细胞对缺氧的反应
- 批准号:
8403872 - 财政年份:2011
- 资助金额:
$ 10.39万 - 项目类别:
Chromatin Modulation Associated with DNA Breakage and Repair in Human Cells
与人类细胞 DNA 断裂和修复相关的染色质调节
- 批准号:
8459323 - 财政年份:2011
- 资助金额:
$ 10.39万 - 项目类别:
ATM, REACTIVE OXYGEN, AND CELLULAR RESPONSES TO HYPOXIA
ATM、活性氧和细胞对缺氧的反应
- 批准号:
8597947 - 财政年份:2011
- 资助金额:
$ 10.39万 - 项目类别:
The role of ATM in Metabolic Stress Responses
ATM 在代谢应激反应中的作用
- 批准号:
9288133 - 财政年份:2011
- 资助金额:
$ 10.39万 - 项目类别:
相似海外基金
Rational design of rapidly translatable, highly antigenic and novel recombinant immunogens to address deficiencies of current snakebite treatments
合理设计可快速翻译、高抗原性和新型重组免疫原,以解决当前蛇咬伤治疗的缺陷
- 批准号:
MR/S03398X/2 - 财政年份:2024
- 资助金额:
$ 10.39万 - 项目类别:
Fellowship
Re-thinking drug nanocrystals as highly loaded vectors to address key unmet therapeutic challenges
重新思考药物纳米晶体作为高负载载体以解决关键的未满足的治疗挑战
- 批准号:
EP/Y001486/1 - 财政年份:2024
- 资助金额:
$ 10.39万 - 项目类别:
Research Grant
CAREER: FEAST (Food Ecosystems And circularity for Sustainable Transformation) framework to address Hidden Hunger
职业:FEAST(食品生态系统和可持续转型循环)框架解决隐性饥饿
- 批准号:
2338423 - 财政年份:2024
- 资助金额:
$ 10.39万 - 项目类别:
Continuing Grant
Metrology to address ion suppression in multimodal mass spectrometry imaging with application in oncology
计量学解决多模态质谱成像中的离子抑制问题及其在肿瘤学中的应用
- 批准号:
MR/X03657X/1 - 财政年份:2024
- 资助金额:
$ 10.39万 - 项目类别:
Fellowship
CRII: SHF: A Novel Address Translation Architecture for Virtualized Clouds
CRII:SHF:一种用于虚拟化云的新型地址转换架构
- 批准号:
2348066 - 财政年份:2024
- 资助金额:
$ 10.39万 - 项目类别:
Standard Grant
The Abundance Project: Enhancing Cultural & Green Inclusion in Social Prescribing in Southwest London to Address Ethnic Inequalities in Mental Health
丰富项目:增强文化
- 批准号:
AH/Z505481/1 - 财政年份:2024
- 资助金额:
$ 10.39万 - 项目类别:
Research Grant
ERAMET - Ecosystem for rapid adoption of modelling and simulation METhods to address regulatory needs in the development of orphan and paediatric medicines
ERAMET - 快速采用建模和模拟方法的生态系统,以满足孤儿药和儿科药物开发中的监管需求
- 批准号:
10107647 - 财政年份:2024
- 资助金额:
$ 10.39万 - 项目类别:
EU-Funded
BIORETS: Convergence Research Experiences for Teachers in Synthetic and Systems Biology to Address Challenges in Food, Health, Energy, and Environment
BIORETS:合成和系统生物学教师的融合研究经验,以应对食品、健康、能源和环境方面的挑战
- 批准号:
2341402 - 财政年份:2024
- 资助金额:
$ 10.39万 - 项目类别:
Standard Grant
Ecosystem for rapid adoption of modelling and simulation METhods to address regulatory needs in the development of orphan and paediatric medicines
快速采用建模和模拟方法的生态系统,以满足孤儿药和儿科药物开发中的监管需求
- 批准号:
10106221 - 财政年份:2024
- 资助金额:
$ 10.39万 - 项目类别:
EU-Funded
Recite: Building Research by Communities to Address Inequities through Expression
背诵:社区开展研究,通过表达解决不平等问题
- 批准号:
AH/Z505341/1 - 财政年份:2024
- 资助金额:
$ 10.39万 - 项目类别:
Research Grant